Icon

ONGLYZA (nda022350)- (EQ 2.5MG BASE,EQ 5MG BASE)

SAXAGLIPTIN HYDROCHLORIDE ASTRAZENECA AB
EQ 2.5MG BASE,EQ 5MG BASE
Yes No
2028-Nov-30 2014-Jul-31
None None
None No
ONGLYZA is a dipeptidyl peptidase-4 (DPP4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
7 3 5
Total Other Developers 3
Drugs with Suitability No
EQ 2.5MG BASE ** ** Up - 3
EQ 5MG BASE ** ** Up - 3
NDA Sales Available Total Generic Sales Available
Yes 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** *************** ******* ******* *********** ***/*-***, ******* ****** **** ***** *********, *****, *********, ******, ***** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.